Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

8.47
BATS BZX Real-Time Price
As of 3:55pm ET
 +0.015 / +0.18%
Today’s Change
6.78
Today|||52-Week Range
11.34
+5.68%
Year-to-Date
Is Prometheus Biosciences a Good Stock to Buy Right Now?
5:32am / MotleyFool.com - Paid Partner Content
Emergent (EBS) OTC Narcan Filing Gets FDA Priority Review Tag
Dec 07 / Zacks.com - Paid Partner Content
4 Stocks to Buy Before the Next Big Bull Rally
Dec 08 / StockNews.com - Paid Partner Content
3 Unparalleled Stocks to Buy That Have Never Been This Cheap
Dec 05 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close8.45
Today’s open8.47
Day’s range8.25 - 9.08
Volume12,099,875
Average volume (3 months)10,372,153
Market cap$9.6B
Data as of 3:55pm ET, 12/09/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2.21%
Earnings growth (next 5 years)+2.84%
Revenue growth (last year)-4.87%
P/E ratioNM
Price/Sales0.56
Price/Book0.93

Competitors

 Today’s
change
Today’s
% change
BBIOBridgeBio Pharma Inc-0.31-3.35%
OASMYVivesto AB0.000.00%
----
IMMBImmunotech Laborator...0.000.00%
Data as of 3:55pm ET, 12/09/2022

Financials

Next reporting dateFebruary 15, 2023
EPS forecast (this quarter)$0.71
Annual revenue (last year)$15.8B
Annual profit (last year)$417.0M
Net profit margin2.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts